Cargando…

Preparation and Characterization of Ion-Sensitive Brimonidine Tartrate In Situ Gel for Ocular Delivery

Brimonidine tartrate (BRT) is a highly selective α2 adrenergic receptor agonist as treatment for patients with open angle glaucoma and high intraocular pressure. The objective of this study was to formulate an ophthalmic ion-sensitive in situ gel (ISG) of BRT to increase the retention time of the dr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xu, Haonan, Liu, Ye, Jin, Lu, Chen, Xu, Chen, Xinghao, Wang, Qiao, Tang, Zhan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9866900/ https://www.ncbi.nlm.nih.gov/pubmed/36678587 http://dx.doi.org/10.3390/ph16010090

Ejemplares similares

Preparation and Evaluation of Nano-vesicles of Brimonidine Tartrate as an Ocular Drug Delivery System
por: Prabhu, P, et al.
Publicado: (2010)

The role of brimonidine tartrate gel in the treatment of rosacea
por: Jackson, J Mark, et al.
Publicado: (2015)

The chemotactic properties of various topical brimonidine tartrate ophthalmic preparations
por: Alonso, Ruiz Simonato, et al.
Publicado: (2020)

Proniosomal gel-derived niosomes: an approach to sustain and improve the ocular delivery of brimonidine tartrate; formulation, in-vitro characterization, and in-vivo pharmacodynamic study
por: Emad Eldeeb, Alaa, et al.
Publicado: (2019)

Fluorimetric Quantification of Brimonidine Tartrate in Eye Drops
por: Sunitha, G., et al.
Publicado: (2013)

Bilateral Lipid Keratopathy in the Setting of Brimonidine Tartrate Use
por: Moshirfar, Majid, et al.
Publicado: (2023)

Formulation and evaluation of stimuli-sensitive hydrogels of timolol maleate and brimonidine tartrate for the treatment of glaucoma
por: Dubey, Akhilesh, et al.
Publicado: (2014)

Use of brimonidine tartrate to resolve telangiectatic matting: case report
por: de Mello, Brenno Augusto Seabra, et al.
Publicado: (2020)

Ocular Distribution of Brimonidine and Brinzolamide after Topical Instillation of a 0.1% Brimonidine Tartrate and 1% Brinzolamide Fixed-Combination Ophthalmic Suspension: An Interventional Study
por: Orii, Yusuke, et al.
Publicado: (2023)

The Role of Topical Brimonidine Tartrate Gel as a Novel Therapeutic Option for Persistent Facial Erythema Associated with Rosacea
por: Johnson, Andrew William, et al.
Publicado: (2015)

Corneal Opacity Induced by Antiglaucoma Agents Other Than Brimonidine Tartrate
por: Kasuya, Yuka, et al.
Publicado: (2020)

Study of Thermo-Sensitive In-Situ Gels for Ocular Delivery
por: Bhowmik, Manas, et al.
Publicado: (2011)

Augmented in vitro and in vivo Profiles of Brimonidine Tartrate Using Gelatinized-Core Liposomes
por: Abdel Azim, Engy A, et al.
Publicado: (2022)

A validated stability-indicating HPLC method for determination of brimonidine tartrate in BRI/PHEMA drug delivery systems
por: Sun, Jianguo, et al.
Publicado: (2017)

Effects of brimonidine tartrate 0.1% ophthalmic solution on the pupil, refraction, and light reflex
por: Kato, C. O. Sayaka, et al.
Publicado: (2018)

Comparisons of efficacy and safety between preserved and preservative-free brimonidine tartrate in glaucoma and ocular hypertension: a parallel-grouped, randomized trial
por: Kim, Ko Eun, et al.
Publicado: (2023)

Brimonidine in the treatment of glaucoma and ocular hypertension
por: Cantor, Louis B
Publicado: (2006)

Tolterodine Tartrate Proniosomal Gel Transdermal Delivery for Overactive Bladder
por: Rajabalaya, Rajan, et al.
Publicado: (2016)

Effect of over-the-counter brimonidine tartrate 0.025% ophthalmic solution on pupil size in healthy adults
por: Nejad, Mitra, et al.
Publicado: (2021)

Effects of brimonidine tartrate 0.2 and 0.15% ophthalmic solution on the static and dynamic pupil characteristics
por: Yang, Jing, et al.
Publicado: (2023)

In situ Gel of Metoprolol Tartrate: Physicochemical Characterization, In vitro Diffusion and Histological Studies
por: Khan, S., et al.
Publicado: (2012)

Preparation and characterization of bear bile-loaded pH sensitive in-situ gel eye drops for ocular drug delivery
por: Ni, Xiaomin, et al.
Publicado: (2020)

Randomized Trial of Brinzolamide/Brimonidine Versus Brinzolamide Plus Brimonidine for Open-Angle Glaucoma or Ocular Hypertension
por: Gandolfi, Stefano A., et al.
Publicado: (2014)

Brimonidine and timolol concentrations in the human vitreous and aqueous humors after topical instillation of a 0.1% brimonidine tartrate and 0.5% timolol fixed-combination ophthalmic solution: An interventional study
por: Orii, Yusuke, et al.
Publicado: (2022)

Nanoparticles laden in situ gel for sustained ocular drug delivery
por: Gupta, Himanshu, et al.
Publicado: (2013)

Preparation and Characterization of Tacrolimus-Loaded SLNs in situ Gel for Ocular Drug Delivery for the Treatment of Immune Conjunctivitis
por: Sun, Kexin, et al.
Publicado: (2021)

The efficacy and safety of add-on 0.1% brimonidine tartrate preserved with sodium chlorite in on-treatment Japanese normal-tension glaucoma patients
por: Tsumura, Toyoaki, et al.
Publicado: (2014)

Prolonged central nervous system and respiratory depression in preterm neonates after exposure to brimonidine tartrate and timolol maleate ophthalmic drops
por: Azarcon, Corrina P., et al.
Publicado: (2020)

Novel long-acting brimonidine tartrate loaded-PCL/PVP nanofibers for versatile biomedical applications: fabrication, characterization and antimicrobial evaluation
por: Salim, Samar A., et al.
Publicado: (2023)

The efficacy and safety of add-on 0.1% brimonidine tartrate preserved with sodium chlorite in on-treatment Japanese normal-tension glaucoma patients [Corrigendum]
Publicado: (2015)

The efficacy and safety of add-on 0.1% brimonidine tartrate preserved with sodium chlorite in on-treatment Japanese normal-tension glaucoma patients [Corrigendum]
Publicado: (2015)

Potential depressive central nervous system effects of brimonidine topical gel
por: Foschi, Cristina, et al.
Publicado: (2020)

Clinical efficacy and neuroprotective effects of brimonidine in the management of glaucoma and ocular hypertension
por: Galanopoulos, Anna, et al.
Publicado: (2009)

Intraocular pressure reduction using a fixed combination of timolol maleate 0.5% and brimonidine tartrate 0.2% administered three times daily
por: Moisseiev, Elad, et al.
Publicado: (2013)

Chitosan-Based In Situ Gels for Ocular Delivery of Therapeutics: A State-of-the-Art Review
por: Irimia, Teodora, et al.
Publicado: (2018)

Nanoparticles Loaded Thermoresponsive In Situ Gel for Ocular Antibiotic Delivery against Bacterial Keratitis
por: Abbas, Muhammad Naseer, et al.
Publicado: (2022)

Combination of brinzolamide and brimonidine for glaucoma and ocular hypertension: critical appraisal and patient focus
por: Nguyen, Quang H
Publicado: (2014)

Preparation of a Paeonol-Containing Temperature-Sensitive In Situ Gel and Its Preliminary Efficacy on Allergic Rhinitis
por: Chu, Kedan, et al.
Publicado: (2013)

Formulation and evaluation of new long acting metoprolol tartrate ophthalmic gels
por: Abou el Ela, Amal El Sayeh F., et al.
Publicado: (2014)

Low‐dose brimonidine for relief of ocular redness: integrated analysis of four clinical trials
por: Ackerman, Stacey L, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_cfo4ir9t95tm925vpt29f9l3g7